Send this to a friend

Biostage's science perseveres through dire financial straits

What’s it like to bring a company back to life after near bankruptcy? Jim McGorry, CEO of Holliston biotech Biostage, explains how the company never lost faith in its science after being delisted from NASDAQ, having an investment agreement fall t ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media